Telix Pharmaceuticals is a biopharmaceutical firm that focuses on developing molecularly targeted radiation therapeutic products.
Business Model:
Revenue: $5.5M
Employees: 2-10
Address: 55 Flemington Road
City: North Melbourne
State: victoria
Zip: 3051
Country: AU
Telix Pharmaceuticals is a biopharmaceutical firm that focuses on developing molecularly targeted radiation therapeutic products.
Contact Phone:
Contact Email:
Listed Exchange:
Australian Securities Exchange
IPO Date:
11/9/2017
IPO Valuation:
$98M
Ticker Symbol:
TLX
IPO Price:
$0.49934317167418246/share
Amount Raised:
$38M
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 7/2019 | Private Placement | - | 11/2017 | IPO | $143.1M |
|
3/2020 | Grant | $500k | 7/2019 | Post-IPO Equity | $40M | 4/2022 | Grant | 1 | $23M |
Australian Government Australian Government |
7/2019 | Private Placement | - |
Portland Investment Counsel Inc Portland Investment Counsel Inc |
---|
Announced Date | Name | Price |
---|---|---|
11/2020 | TheraPharm | |
11/2018 | Advanced Nuclear Medicine Ingredients | |
9/2018 | Atlab Pharma |
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|